Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (BEIGF) Shares Issued (2016 - 2025)

Historic Shares Issued for BeOne Medicines (BEIGF) over the last 10 years, with Q3 2025 value amounting to $80.5 million.

  • BeOne Medicines' Shares Issued rose 39642.48% to $80.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.8 million, marking a year-over-year increase of 36530.37%. This contributed to the annual value of $45.4 million for FY2024, which is 1855.79% down from last year.
  • BeOne Medicines' Shares Issued amounted to $80.5 million in Q3 2025, which was up 39642.48% from $33.1 million recorded in Q2 2025.
  • BeOne Medicines' Shares Issued's 5-year high stood at $3.4 billion during Q4 2021, with a 5-year trough of $50000.0 in Q3 2021.
  • Over the past 5 years, BeOne Medicines' median Shares Issued value was $14.8 million (recorded in 2024), while the average stood at $195.9 million.
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 9999.76% in 2021, then skyrocketed by 3331000.0% in 2022.
  • Over the past 5 years, BeOne Medicines' Shares Issued (Quarter) stood at $3.4 billion in 2021, then crashed by 99.66% to $11.3 million in 2022, then tumbled by 70.23% to $3.4 million in 2023, then surged by 161.76% to $8.8 million in 2024, then soared by 815.69% to $80.5 million in 2025.
  • Its last three reported values are $80.5 million in Q3 2025, $33.1 million for Q2 2025, and $63.4 million during Q1 2025.